About Volta Labs
Volta Labs focuses on genomic analysis by developing software tools that help research institutions, clinical laboratories, and biotech companies process genomic data accurately and efficiently. Their software is designed to generate precise results from genomic samples, which is essential for advancements in personalized medicine and biotechnology. Unlike many competitors, Volta Labs combines software development with advanced biochemistry, allowing them to create specialized applications tailored to the needs of their clients. The company's goal is to enhance the efficiency and accuracy of genomic analysis, ultimately unlocking the potential of genomic data for a wider audience.
Cambridge, MassachusettsHeadquarters
2018Year Founded
$23.6MTotal Funding
EARLY_VCCompany Stage
Enterprise Software, Biotechnology, HealthcareIndustries
51-200Employees
Benefits
Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
401(k) Company Match
Paid Vacation
Paid Holidays
Paid Parental Leave
Paid Time Off
Sponsored Commuter Benefit Plans
Robust Equity Program
Stock Options
Risks
Emerging startups in genomics automation could threaten Volta Labs' market share.
Reliance on partnerships may pose risks if partners develop competing technologies.
Data privacy concerns could impact Volta Labs' data monetization strategies.
Differentiation
Volta Labs integrates software development with biochemistry for advanced genomic solutions.
The Callisto Sample Prep System offers push-button protocols reducing operational costs.
Volta Labs' platform-agnostic solutions enhance accessibility in next-generation sequencing.
Upsides
Growing demand for automated genomic solutions due to personnel shortages.
Partnerships with companies like Element Biosciences enhance sequencing efficiency and cost-effectiveness.
Volta Labs' digital fluidics platform maximizes performance and scalability in sample preparation.
Funding
Total raised$23.60 M
Latest valuation$100.00 M
StageEARLY_VC
EARLY VC
12/31/2023$4
$100.00 M